AAIPharma Names New President for European Operations
Posted May 3, 2006
WILMINGTON, N.C. — John Hall, a former executive with Quintiles, is the new president of European operations for
Hall, who has more than 30 years of experience in the pharmaceutical, chemical and consulting fields, most recently was senior vice president for corporate development at PharmaBio Development, a Quintiles subsidiary. He also has served as general manager for Quintiles Limited in Europe.
"The appointment of Dr. Hall as President of European Operations is an important step in building a world-class drug development organization," said Ludo Reynders, president and chief executive officer of AAIPharma. "We have made significant progress strengthening our North American operations, and we will now focus on European growth."
AAIPharma recently emerged from bankruptcy and is now privately held. Reynders is a former Quintiles executive.